A Comparison of Nucleolar Organizer Region Staining and Ki-67 Immunostaining in Non-Hodgkin's Lymphoma
Overview
Pathology
Authors
Affiliations
Eighty cases of non-Hodgkin's lymphomas were examined independently using the monoclonal antibody Ki-67 and an argyrophilic method for the demonstration of nucleolar organizer regions. The evidence that Ki-67 immunoreactivity may be used as a marker of cell proliferation is described and the nature of nucleolar organizer regions reviewed. The proportion of tumour cells with nuclear Ki-67 immunoreactivity and the mean number of nuclear organizer regions are shown to be linearly related (r = 0.86, P less than 0.001) although some scatter was observed. These data suggest that the mean number of nucleolar organizer regions may reflect the cellular kinetics of a tumour. This study also provides further evidence supporting the thesis that the mean nucleolar organizer region score is related to the histological grade of non-Hodgkin's lymphoma. Ki-67 immunostaining and nucleolar organizer region staining would seem to provide comparable data, at least in non-Hodgkin's lymphoma, but the latter method has the advantage of being applicable to conventionally fixed and processed paraffin sections.
AgNOR patterns and configurations in adult acute leukemia patients.
Gajewska M, Kwiecien I, Rutkowska E, Rzepecki P, Sulek K Cent Eur J Immunol. 2023; 47(4):323-331.
PMID: 36817394 PMC: 9901258. DOI: 10.5114/ceji.2022.124252.
Cancado R, Yurgel L, Filho M Tob Induc Dis. 2009; 2(1):43-9.
PMID: 19570270 PMC: 2671520. DOI: 10.1186/1617-9625-2-1-43.
AgNOR clusters as a parameter of cell kinetics in chronic lymphocytic leukaemia.
Lorand-Metze I, Metze K Clin Mol Pathol. 1996; 49(6):M357-60.
PMID: 16696103 PMC: 408087. DOI: 10.1136/mp.49.6.m357.
Molecular and biochemical aspects of interphase nucleolar organiser regions.
Crocker J Clin Mol Pathol. 1996; 49(1):M8-M11.
PMID: 16696049 PMC: 408010. DOI: 10.1136/mp.49.1.m8.
Techniques to assess the proliferative potential of brain tumors.
Quinones-Hinojosa A, Sanai N, Smith J, McDermott M J Neurooncol. 2005; 74(1):19-30.
PMID: 16078103 DOI: 10.1007/s11060-004-5758-0.